Harvard Bioscience Inc (HBIO)
3.82
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
3.82
0.00 (0.00%)
Pre-Market: 20:00
Harvard Bioscience Accounts Payable (Quarterly): 5.554M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 5.554M |
September 30, 2023 | 6.269M |
June 30, 2023 | 4.716M |
March 31, 2023 | 5.978M |
December 31, 2022 | 6.447M |
September 30, 2022 | 5.877M |
June 30, 2022 | 6.81M |
March 31, 2022 | 6.218M |
December 31, 2021 | 4.911M |
September 30, 2021 | 5.616M |
June 30, 2021 | 7.489M |
March 31, 2021 | 6.416M |
December 31, 2020 | 5.972M |
September 30, 2020 | 5.99M |
June 30, 2020 | 6.596M |
March 31, 2020 | 6.625M |
December 31, 2019 | 5.339M |
September 30, 2019 | 5.266M |
June 30, 2019 | 6.041M |
March 31, 2019 | 7.311M |
December 31, 2018 | 7.359M |
September 30, 2018 | 5.392M |
June 30, 2018 | 7.718M |
March 31, 2018 | 7.359M |
December 31, 2017 | 4.41M |
Date | Value |
---|---|
September 30, 2017 | 5.607M |
June 30, 2017 | 5.583M |
March 31, 2017 | 5.835M |
December 31, 2016 | 6.196M |
September 30, 2016 | 6.142M |
June 30, 2016 | 6.577M |
March 31, 2016 | 6.172M |
December 31, 2015 | 8.782M |
September 30, 2015 | 6.322M |
June 30, 2015 | 8.834M |
March 31, 2015 | 7.18M |
December 31, 2014 | 6.294M |
September 30, 2014 | 5.052M |
June 30, 2014 | 5.06M |
March 31, 2014 | 4.667M |
December 31, 2013 | 4.682M |
September 30, 2013 | 4.657M |
June 30, 2013 | 4.877M |
March 31, 2013 | 4.429M |
December 31, 2012 | 4.68M |
September 30, 2012 | 4.141M |
June 30, 2012 | 4.607M |
March 31, 2012 | 4.92M |
December 31, 2011 | 4.959M |
September 30, 2011 | 5.265M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
4.716M
Minimum
Jun 2023
7.489M
Maximum
Jun 2021
6.007M
Average
5.99M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Bruker Corp | 202.70M |
Azenta Inc | 40.24M |
Bionano Genomics Inc | 10.38M |
Akoya Biosciences Inc | 11.78M |
Singular Genomics Systems Inc | 2.587M |